Accendra Health

Moat components and our scores: Intangible assets 55/100 (national brands Apria and Byram but limited brand loyalty in insurer-driven channels). Switching costs 60/100 (payer contracts, referral relationships and documentation workflows create moderate friction; individual patient switching remains feasible).

Network effects 20/100 (limited true two-sided network dynamics). Cost advantages 65/100 (scale purchasing, vendor rebates, national logistics and in-home clinical coverage help on unit costs). Efficient scale 55/100 (local market density matters, although competitors such as AdaptHealth and Lincare also have scale).

Overall moat is a blend of payer-process stickiness and scale rather than customer love, and it can erode if service levels slip or payers rebid volumes aggressively. The large 2025 payer contract termination underscores fragility.